Novartis has invested in Credence, confirming its interest in employing Credence technology for its injectable medicines. The investment is geared towards supporting Credence’s ramp-up of manufacturing capacity for its innovative drug delivery systems and enabling commercial supply of Credence devices to the pharmaceutical market. MENLO PARK, Calif.–(BUSINESS WIRE)–January 26, 2021– Credence MedSystems announced today that […]